# Faeth Therapeutics, Inc.: Form 8-K, filed Mar 7, 2023

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: 8-K
- Filed: 2023-03-07
- Accepted by EDGAR: Mar 7, 2023, 17:30 ET
- Period: 2023-03-07
- Accession: 0001193125-23-063316
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000119312523063316/d470831d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000119312523063316/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000119312523063316/d470831d8k.htm

Filed Mar 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-063316. Last ingested by Listed: Nov 9, 2026, 18:03 ET. No prices; not investment advice.